Ticker
ADAPCompany Name
ADAPTIMMUNE THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
6/30/2025 | $ -191.67M | -925.24% | $ 20.72M |
3/31/2025 | $ -109.83M | -165.43% | $ 66.4M |
12/31/2024 | $ -74.09M | -103.78% | $ 71.4M |
9/30/2024 | $ -55.17M | -27.91% | $ 197.68M |
6/30/2024 | $ -46.03M | -16.48% | $ 279.32M |
3/31/2024 | $ -137.98M | -43.45% | $ 317.53M |
12/31/2023 | $ -145.56M | -34.42% | $ 422.92M |
9/30/2023 | $ -131.43M | -102.58% | $ 128.13M |
6/30/2023 | $ -144.15M | -74.83% | $ 192.63M |
3/31/2023 | $ -149.38M | -65.67% | $ 227.47M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Market Cap
(=) FCF Yield
FCF Yield for ADAPTIMMUNE THERAPEUTICS PLC is calculated as follows: FCF [ $ -38.24M ] / Market Cap [ $ 823.52M ]
(=) FCF Yield [ -4.64% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.59% |
median | 3.22% |
std | 11.38% |